Stock listing
Zyus Life Sciences Corporation
Selected listing: ZLSCF · OTC · USD · US
Zyus Life Sciences Corporation (OTC:ZLSCF), Health Technology. Latest release Oct 1, 2026: ZYUS Life Sciences Announces Positive Topline Results from Phase 2a…
- Ticker
- OTC:ZLSCF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Zyus Life Sciences Corporation
The company focuses on the development and production of cannabis-based products for medical use. Zyus aims to provide innovative solutions in the life sciences sector, contributing to the evolving landscape of healthcare.
Latest news from Zyus Life Sciences Corporation
ZYUS Life Sciences Announces Positive Topline Results from Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug in Patients with Advanced Cancer
October 1, 2026
ZYUS Life Sciences Announces Positive Topline Results from Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug in Patients with Advanced Cancer
October 1, 2026
ZYUS Life Sciences Corporation Announces Planned Release Date for Phase 2a Clinical Trial Results, Annual General Meeting Results and Change in Audit Committee Chair
September 23, 2026
ZYUS Life Sciences Corporation Provides General Business Update and Announces Changes in Executive Leadership
September 15, 2026
Canadian Investment Regulatory Organization Trade Resumption - ZYUS
September 11, 2026
Research Zyus Life Sciences Corporation
Zyus Life Sciences Corporation company profile
View the public company page for Zyus Life Sciences Corporation on 6ix.
Zyus Life Sciences Corporation news
Read company news and market updates connected to Zyus Life Sciences Corporation.
Zyus Life Sciences Corporation investor events
Find investor webinars, events, and replay context for Zyus Life Sciences Corporation.